A0A2J8SGT2 (A0A2J8SGT2_PONAB) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)
Bcl-2-like protein 11 UniProtKBInterProInteractive Modelling
198 aa; Sequence (Fasta) ;
6 identical sequences: Homo sapiens: O43521; Pan troglodytes: H2R0F7, A0A6D2X3E6; Pan paniscus: A0A2R9CA30; Gorilla gorilla gorilla: A0A2I2ZL36; Nomascus leucogenys: G1QPE5
Available Structures
45 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Bak in complex with Bim-h3Pc |
Heteromer O43521; Q16611; | 96.15 | 2×1PG; 1×NH4; | |||
| Bak core latch dimer in complex with Bim-h3Pc-RT |
Heteromer O43521; Q16611; | 88.0 | 2×PO4; | |||
| Bak in complex with Bim-h3Glg |
Heteromer O43521; Q16611; | 88.0 | 6×MG; 1×EDO; | |||
| Bim BH3 peptide in complex with Bcl-xL |
Heteromer O43521; Q07817; | 100 | ||||
| Mcl-1 in complex with Bim-h3Pc-RT |
Heteromer O43521; P97287; Q07820; | 86.96 | 3×EDO; | |||
| Bak core latch dimer in complex with Bim-BH3 - Cubic |
Heteromer O43521; Q16611; | 92.0 | 1×TFA; 6×EDO; 1×CL; 1×GOL; | |||
| Human Bcl2-A1 in complex with Bim-BH3 peptide |
Heteromer O43521; Q16548; | 100 | 1×SO4; | |||
| Bak core latch dimer in complex with Bim-RT - Tetragonal |
Heteromer O43521; Q16611; | 92.0 | 1×MPD; 2×BR; 1×IMD; | |||
| Crystal Structure of a pro-survival Bcl-2:Bim BH3 complex |
Heteromer O43521; Q9HD36; | 100 | 1×PG4; | |||
| Crystal structure of the Mcl-1:Bim BH3 complex |
Heteromer O43521; P97287; Q07820; | 100 | 7×ZN; 1×CL; | |||
| Mcl-1 in complex with Bim BH3 mutant I2dY |
Heteromer O43521; Q07820; | 95.65 | 1×TRS; | |||
| Bcl-xL in complex with Bim-h3Pc-RT |
Heteromer O43521; Q07817; | 85.71 | 6×EDO; | |||
| Crystal structure of Mcl-1 in complex with an Mcl-1 selective BH3 ligand |
Heteromer O43521; P97287; Q07820; | 91.3 | 4×ZN; | |||
| BimL12F in complex with Bcl-xL |
Heteromer O43521; Q07817; | 95.65 | 1×ZN; | |||
| Structure of human Mcl-1 in complex with BIM BH3 peptide |
Heteromer O43521; Q07820; | 100 | 4×ZN; | |||
| BimL12Y in complex with Mcl-1 |
Heteromer O43521; P97287; Q07820; | 95.65 | 4×ZN; | |||
| Bak core latch dimer in complex with Bim-h0-h3Glt |
Heteromer O43521; Q16611; | 69.56 | 3×EDO; | |||
| Crystal Structure of a BHRF-1 : Bim BH3 complex |
Heteromer O43521; P0C736; | 100 | 5×BR; | |||
| Crystal structure of anti-apoptotic BHRF1 in complex with the Bim BH3 domain |
Heteromer O43521; P0C6Z1; | 100 | 9×BR; 2×GOL; | |||
| Crystal Structure of core/latch dimer of Bax in complex with BimBH3 |
Heteromer O43521; Q07812; | 100 | 2×EDO; | |||
| Vaccinia Virus F1L bound to Bim BH3 |
Heteromer O43521; O57173; | 100 | 2×MRD; 8×CL; | |||
| De novo design of high-affinity protein binders to bioactive helical peptides |
Heteromer O43521; | 100 | ||||
| Structural insight into tanapoxvirus mediated inhibition of apoptosis |
Heteromer O43521; Q9DHU6; | 100 | 2×NA; | |||
| Crystal structure of Bcl-xL in complex with BIM BH3 domain |
Heteromer O43521; Q07817; | 100 | ||||
| Human Mcl-1 in complex with a modified Bim BH3 peptide |
Heteromer O43521; Q07820; | 76.19 | ||||
| Mcl-1 in complex with Bim BH3 mutant I2dA |
Heteromer O43521; Q07820; | 95.24 | 5×ZN; 1×ACT; 1×CL; | |||
| Human Mcl-1 in complex with a modified unnatural Bim BH3 peptide |
Heteromer O43521; Q07820; | 76.19 | 1×ADM; | |||
| Bcl-2 alpha beta-1 LINEAR complex |
Heteromer O43521; P10415; Q07817; | 76.19 | ||||
| Mcl-1 in complex with Bim BH3 mutant F4aE |
Heteromer O43521; Q07820; | 95.24 | 4×ZN; 1×ACT; | |||
| Structural and functional insights into Canarypox Virus CNP058 regulation of apoptosis |
Heteromer O43521; Q6VZT9; | 100 | ||||
| BAX Activation is Initiated at a Novel Interaction Site |
Heteromer O43521; Q07812; | 100 | ||||
| Bcl-2 alpha beta-1 complex |
Heteromer O43521; P10415; Q07817; | 73.68 | ||||
| Crystal structure of alpha-beta-foldamer 2c in complex with Bcl-xL |
Heteromer O43521; Q07817; | 100 | 2×CL; 1×SO4; | |||
| Structure of Bcl-xL bound to BimSAHB |
Heteromer O43521; Q07817; | 88.89 | 14×GOL; | |||
| Structure of Bcl-xL bound to BimLOCK |
Heteromer O43521; Q07817; | 88.89 | 2×GOL; | |||
| Crystal structure of Bcl-xL in complex with the BIM BH3 domain containing Ile155-to-Arg and Glu158-… |
Heteromer O43521; Q64373; | 88.89 | 1×ACT; 2×CL; | |||
| Crystal structure of alpha-beta foldamer 4c in complex with Bcl-xL |
Heteromer O43521; Q07817; | 88.23 | ||||
| Deerpox virus DPV022 in complex with Bim BH3 |
Heteromer O43521; Q08FX8; | 100 | ||||
| Bfl-1 in complex with alpha helical peptide |
Heteromer O43521; Q16548; | 70.59 | ||||
| Crystal Structure of core/latch dimer of Bax in complex with BimBH3mini |
Heteromer O43521; Q07812; | 100 | ||||
| Crystal structure of Bcl-xl bound to BIM-MM |
Heteromer O43521; Q07817; | 87.5 | ||||
| Crystal Structure of core/latch dimer of Bax in complex with BimBH3mini |
Heteromer O43521; Q07812; | 100 | ||||
| Crystal structure of Mcl-1 in complex with 138E12 peptide, Lys-covalent antagonist |
Heteromer O43521; Q07820; | 75.0 | ||||
| SOLUTION STRUCTURE OF DYNEIN LIGHT CHAIN 8 (DLC8) AND BIM PEPTIDE COMPLEX |
Heteromer O43521; P63170; | 100 | ||||
| BimBH3 peptide tetramer | homo-4-mer | 100 | 1×SCN; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 1pq1.1.B | monomer | 0.69 | 75.76 | |||